Hynes M, Calder P, Scott G
Bone and Joint Research Unit, The Royal London Hospital, Whitechapel, London, UK.
Knee. 2003 Dec;10(4):375-7. doi: 10.1016/s0968-0160(03)00044-9.
The fall in haemoglobin following unilateral total knee arthroplasty is reduced by tranexamic acid administration.
60 patients were studied in total, 30 received tranexamic acid 10 mg/kg on induction and a further dose shortly before the release of the tourniquet. Surgery was performed by the senior author in a standardised fashion using the Freeman Samuelson cemented total knee replacement. Haemoglobin levels were measured 2 weeks pre and 3 days post operatively. Any complications were noted. A control group was matched using the Bone and Joint Research Unit database for age, sex, disease and pre-operative haemoglobin level. This group had been monitored in the same way as the group treated with tranexamic acid.
In the group receiving no tranexamic acid the mean fall in haemoglobin was 2.8 g/dl (95% CI of mean 2.5-3.2) and in the group treated with tranexamic acid 1.7 g/dl (95% CI of mean 1.3-2) P<0.01. There were no complications in either group.
The administration of tranexamic acid is an effective method of reducing the haemoglobin fall following knee arthroplasty.
通过给予氨甲环酸可减少单侧全膝关节置换术后血红蛋白的下降。
共研究60例患者,30例在诱导时接受10mg/kg氨甲环酸,并在松开止血带前不久再给予一剂。手术由资深作者以标准化方式进行,采用弗里曼·萨缪尔森骨水泥型全膝关节置换术。在术前2周和术后3天测量血红蛋白水平。记录所有并发症。使用骨与关节研究单位数据库,按照年龄、性别、疾病和术前血红蛋白水平匹配对照组。该组的监测方式与接受氨甲环酸治疗的组相同。
未接受氨甲环酸治疗的组中,血红蛋白平均下降2.8g/dl(均值的95%置信区间为2.5 - 3.2),接受氨甲环酸治疗的组中血红蛋白平均下降1.7g/dl(均值的95%置信区间为1.3 - 2),P<0.01。两组均无并发症。
氨甲环酸给药是减少膝关节置换术后血红蛋白下降的有效方法。